Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study - Li Bassi, Gianluigi; Motos, Ana; Fernandez-Barat, Laia; Aguilera Xiol, Eli; Chiurazzi, Chiara; Senussi, Tarek; Saco, Maria A; Fuster, Carla; Carbonara, Marco; Bobi, Joaquim; Amaro, Rosanel; De Rosa, Francesca; et al. (Critical care medicine, 2019)
Keywords: Administration, Inhalation; Administration, Intravenous; Amikacin - administration & dosage; Amikacin - pharmacology; Animals; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - pharmacology; Bacterial Load - drug effects; Bronchoalveolar Lavage Fluid - microbiology; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin - administration & dosage; Fosfomycin - pharmacology; Lung - microbiology; Lung - pathology; Meropenem - administration & dosage; Meropenem - pharmacology; Nebulizers and Vaporizers; Pneumonia - drug therapy; Pneumonia - microbiology; Pneumonia - pathology; Prospective Studies; Pseudomonas aeruginosa - drug effects; Pseudomonas Infections - complications; Pseudomonas Infections - drug therapy; Random Allocation; Swine; Trachea - metabolism; Trachea - microbiology